Gainers
• Immunic, Inc. IMUX stock increased by 60.63% to $13.75 during Wednesday's pre-market session.
• Neon Therapeutics, Inc. NTGN stock increased by 31.28% to $3.19.
• BioNTech, Inc. BNTX shares increased by 23.57% to $52.22. The most recent rating by H.C. Wainwright, on Apr 13, is at Neutral, with a price target of $48.
• Novus Therapeutics, Inc. NVUS stock moved upwards by 17.73% to $0.68.
• Myovant Sciences, Inc. MYOV stock rose 14.61% to $13.26. The most recent rating by Citigroup, on Feb 3, is at Neutral, with a price target of $15.
• DBV Technologies, Inc. DBVT shares increased by 11.51% to $5.23. The most recent rating by Citigroup, on Apr 6, is at Buy, with a price target of $10.
• Precipio, Inc. PRPO stock moved upwards by 10.15% to $0.65.
• Compugen, Inc. CGEN stock moved upwards by 7.45% to $15. The most recent rating by Roth Capital, on Apr 22, is at Buy, with a price target of $28.
• Vascular Biogenics, Inc. VBLT shares moved upwards by 7.41% to $1.45. The most recent rating by Oppenheimer, on Apr 17, is at Outperform, with a price target of $3.
• Trillium Therapeutics, Inc. TRIL stock rose 7.03% to $4.57.
Losers
• VBI Vaccines, Inc. VBIV shares fell 30.13% to $1.09 during Wednesday's pre-market session.
• Conatus Pharmaceuticals, Inc. CNAT stock declined 11.71% to $0.30.
• SCWorx, Inc. WORX shares declined 10.51% to $5.15.
• Biogen, Inc. BIIB stock decreased by 5.20% to $311.90. The most recent rating by Barclays, on Feb 27, is at Overweight, with a price target of $389.
• Vaxart, Inc. VXRT shares fell 5.06% to $3.
• Advaxis, Inc. ADXS stock declined 4.90% to $0.58.
• Invitae, Inc. NVTA shares decreased by 4.20% to $14.60. The most recent rating by Benchmark, on Apr 8, is at Buy, with a price target of $20.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.